Skip to content

To evaluate the safety and efficacy of laparoscopy assisted laparoscopic radical resection of esophageal cancer

To evaluate the safety and efficacy of laparoscopy assisted laparoscopic radical resection of esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080760
Enrollment
Unknown
Registered
2024-02-06
Start date
2024-02-22
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma of esophagus

Interventions

Sponsors

Harbin Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The clinical diagnosis of esophageal cancer required radical resection of esophageal cancer, and the pathological diagnosis was middle-lower esophageal squamous cell carcinoma with TNM stages of T1b-2, N0, M0; (2) Age 18-75 years old (inclusive), gender is not limited; (3) Be able to cooperate with and complete follow-up and related examinations; (4) Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with pulmonary tuberculosis, pulmonary infection, and severe thoracic adhesion; (2) Esophageal cancer combined with severe abdominal adhesion, combined with ascites or ascites signs caused by esophageal cancer, there are obvious signs of external invasion and perforation (such as hoarseness, choking, etc.); (3) Emergency surgery; (4) severe coagulation dysfunction, obvious bleeding tendency; (5) severe comorbidities, unable to tolerate surgery or anesthesia; (6) Pregnant or lactating women; (7) Participating in other investigational drug or device clinical trials not completed; (8) Patients considered unsuitable for participation in this project by the investigator.

Design outcomes

Primary

MeasureTime frame
No conversion rate;

Secondary

MeasureTime frame
The number of lymph node dissection;

Countries

China

Contacts

Public ContactMa Jianqun

Harbin Medical University Cancer Hospital

Jianqunma@aliyun.com+86 133 5999 0466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026